Giving hope: 5 year celebration pancreatic cancer-free
Thanks so much to Dr. Nagorney and Michelle Williamson and all the other doctors involved for me to be celebrating 5 years cancer free from pancreatic cancer! It's great to be alive!! Thanks again! ♥️
Interested in more discussions like this? Go to the Pancreatic Cancer Support Group.
The Whipple procedure since 1935 was considered the only method of cure and that was if one had a very early stage. There are some stage IV survivors that were cured using chemo drugs designed for colon cancer. They are around but not many of them. The original version of Folfirinox was FDA approved for pancreatic cancer in 2011. The modified version was FDA approved in 2018. There is now sufficient data since the original version of Folfirinox began being used in clinical trials prior to 2011 of long-term survivors who were stage III and stage IV.
5-Fluorouricil (5-FU) is a component of Folfirinox. It was developed to treat colon cancer and then was found to have benefit in pancreatic cancer. As I mentioned previously, I got Folfirinox for six cycles and then the irinotecan and oxaliplatin were removed so I was just getting the 5-FU component with Leucovorin as resting cycles to reduce the chance of permanent neuropathy. My tumors continued to respond significantly to the 5-FU alone.
The best experienced medical centers for treating pancreatic cancer are the ones that are NCI designated centers of excellence in cancer treatment with a Hepatobiliary department or even better, one with a pancreas program. I went into NYC and chose Weill Cornell. The Hepatobiliary program was headed by a world renowned surgeon who at that point in his career had done over 1500 Whipples and was part of a group of three that pioneered a liver transplantation technique. He was a very skilled surgeon with vascular surgery skills that was at the right place and the right time when portal vein involvement was discovered while in surgery.
During standard of care treatment with Folfirinox I had genetic testing done. It was not standard practice in 2012 to do on pancreatic cancer patients then. It found a BRCA mutation and the geneticist suggested I search for a PARP-1 inhibitor trial. It took 14 months and I happened to find it before it was publicly announced. That’s an interesting story for another time. I was the first patient in the USA to enroll in the trial and the longest pancreatic cancer patient in the world on that drug. The trial was at Abramson Cancer Center of the University of Pennsylvania. I continue to go there for long-term following being on that experimental drug.
Regarding multiple opinons-absolutely. Contact the Pancreatic Cancer Action Network at 877.272.6226, M-F, 7:00am-5:00pm PT. They can provide a list of skilled surgeons and facilities by State and region. Most surgeons would not have continued the Whipple when vascular involvement was found. Two of the three surgeons on the surgical team were also transplant specialists with vascular surgery skills in addition to doing the Whipple. So they were equipped to handle the challenges. Surgeons skills vary and why you Ned to find one with the expertise that can do the surgery.
Definitely seems to be a familial pattern. Not all cancer genes have yet been characterized. Did you see a genetics counselor? I am not sure if there is a research institution doing research on cancer genetics that is working on this issue but it just has got to be out there somewhere. My daughter is at risk for BRCA, finally agreed to genetic testing. It will be done as a virtual visit at MSKCC. This is standard screening.
Thank you for sharing your story. I am five weeks out from my Whipple. I love the methodical approach that you took to your treatment. This gives us all hope.
I can’t stress enough the importance of self-advocacy. It requires reading and asking questions to be able to make informed decisions and taking an active role in being part of one’s care team.
Absolutely must advocate for ourselves. I was pronounced NED and it feels like all doctors in my life have disappeared. I do have follow up appointments but I somewhat feel I am in a “wait and see” loop.
So I am trying to arrange consults with Mayo, MSK and John’s Hopkins. So far have appt at JH. I have a great surgeon but I need second opinions on how to be proactive now. My oncologist feels so nothing right now but surveillance. Just not aure I am comfortable with this…
Second opinion at an expert center seems like a really great idea.
I am also learning that having a genetics consult more than once can be useful. Each year more genes are being added to the test. With cancers that continue to have some mystery about them, this seems useful. A friend with Lynch Syndrome gets hers done every two years by a specialists’ recommendation.
I can so relate to your post (I had a resected PDAC w/KRAS mutation). My 20-month scan showed NED and my oncologist thought it was a waste of time to try Natera's blood test for ctDNA or even continue with my monthly blood tests (CA19-9 doesn't work for me, but I want to keep an eye on glucose and other measurements). He did order a 24th month scan, but since I've been the one requesting scans every four or five months, I'm not clear if it was because I asked for it or he recommended it.
I also like the posts recommending follow-up DNA testing. Haven't done that yet, but I'll look into it.
Can't help but wonder if it's the individual doctor or the facility's approach to pancreatic cancer patients since our stats are so discouraging? When I look around the internet, I see a tremendous amount of testing and research in the works. To my eye, there are a lot of very smart people who are passionate about finding a cure for us along with the charitable contributions to help. I see plenty of evidence that it's worth self-advocacy and being proactive. The discouraging aspect is (for many of us) we are simply left to try and navigate a system we were never prepared for.
@patti303 , The Signatera ctDNA test was late detecting my PDAC recurrence, but eventually caught up with my MRI and confirmed the cancer was back.
One of my onco nurses told me the Signatera was not super-sensitive to certain solid tumors. Basically, if it detects cancer, you have cancer; if it doesn't detect cancer, you might still have cancer.
Nonetheless, I would rather do as much non-invasive testing as possible, and risk getting a false positive that requires follow-up than to remain uninformed when something *might* be there that you'll never find if you don't test.
Never let one test result be the sole basis of a treatment plan, unless it's near 100% unequivocal or you have no time for alternatives. Err on the side of caution! I had 3 different blood tests and a biopsy saying "no cancer" but an MRI saying there probably was. Follow-on bloodwork eventually caught up and confirmed the MRI was correct. The multiple false negatives gave me a false sense of "blissful ignorance" but no more so than if I had not been testing.
@markymark911
This was so helpful. Where did your cancer reoccur?
Was it a metastasis elsewhere or in your pancreas bed where surgery was performed?